Jinjun Chen Selected Research

Creatinine

10/2023	ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial.
6/2023	New Algorithm Rules Out Acute-on-chronic Liver Failure Development within 28 Days from Acute Decompensation of Cirrhosis.
1/2023	A novel prognostic nomogram for older patients with acute-on-chronic liver diseases (AoCLD): a nationwide, multicentre, prospective cohort study.
2/2020	Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies.
8/2014	[Clinical characteristics of patients with acute-on-chronic liver failure and splenomegaly].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinjun Chen Research Topics

Disease

16	Fibrosis (Cirrhosis) 01/2024 - 09/2016
11	Liver Diseases (Liver Disease) 01/2024 - 08/2014
10	Infections 01/2023 - 09/2002
8	Chronic Hepatitis B 01/2022 - 01/2009
7	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 07/2016
6	Acute-On-Chronic Liver Failure 01/2023 - 01/2019
3	Hepatitis 02/2024 - 08/2016
3	Thrombosis (Thrombus) 12/2023 - 01/2022
3	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2018
3	Hepatic Encephalopathy 05/2023 - 08/2014
3	End Stage Liver Disease 01/2023 - 01/2018
3	Hemorrhage 01/2023 - 02/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2019
3	Neuralgia (Stump Neuralgia) 03/2022 - 01/2018
3	Inflammation (Inflammations) 01/2022 - 01/2013
3	Cryptorchidism (Undescended Testes) 05/2016 - 01/2015
2	Neoplasms (Cancer) 05/2024 - 01/2019
2	Bacterial Infections (Bacterial Infection) 12/2023 - 06/2023
2	Ascites 01/2023 - 01/2022
2	Carcinogenesis 01/2021 - 01/2021
2	Liver Failure 01/2021 - 01/2020
1	Cardiotoxicity 05/2024
1	Congenital Abnormalities (Deformity) 05/2024
1	Gram-Positive Bacterial Infections 02/2024
1	Chemical and Drug Induced Liver Injury 02/2024
1	Varicose Veins (Varicose Vein) 12/2023
1	Atrophy 10/2023
1	Diarrhea 10/2023
1	Drug-Related Side Effects and Adverse Reactions 10/2023
1	Headache (Headaches) 10/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 05/2023
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 03/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Peritonitis 01/2022
1	Virus Diseases (Viral Diseases) 04/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2021
1	Renal Colic 01/2021
1	Obesity 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Nausea 01/2021
1	Abdominal Obesity 01/2021

Drug/Important Bio-Agent (IBA)

9	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2009
5	CreatinineIBA 10/2023 - 08/2014
5	BilirubinIBA 06/2023 - 02/2020
5	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2016
5	Hepatitis B e AntigensIBA 06/2015 - 09/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 02/2020
4	Alanine Transaminase (SGPT)IBA 01/2024 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2012
3	SodiumIBA 01/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2018
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2012 - 01/2009
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024 - 12/2023
2	Urea (Carbamide)FDA LinkGeneric 01/2023 - 01/2022
2	NitrogenIBA 01/2023 - 01/2022
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 01/2018
2	nasIBA 01/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 09/2021 - 01/2021
2	fibrin fragment D (D-dimer)IBA 10/2020 - 01/2019
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2016 - 05/2016
2	Diethylhexyl Phthalate (DEHP)IBA 01/2015 - 01/2015
2	Endocrine DisruptorsIBA 01/2015 - 01/2015
1	3,4,5,3',4'-pentachlorobiphenylIBA 05/2024
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	Antitubercular AgentsIBA 02/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	Guanidine (Guanidine Nitrate)FDA Link 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	AntioxidantsIBA 10/2023
1	Phosphodiesterase InhibitorsIBA 10/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2023
1	Pyrrolizidine AlkaloidsIBA 03/2023
1	PotassiumIBA 01/2023
1	AlbuminsIBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	4-chlorophenyl methyl sulfide (CPMS)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 04/2021
1	Messenger RNA (mRNA)IBA 04/2021
1	IronIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	lornoxicamIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021

Therapy/Procedure

16	Therapeutics 12/2023 - 01/2009
2	Liver Transplantation 01/2024 - 01/2023
1	Artificial Liver (Bioartificial Liver) 05/2023
1	Fecal Microbiota Transplantation 01/2022
1	Intramuscular Injections 01/2021
1	Acupuncture Therapy 01/2021
1	Transplantation 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Sclerotherapy 10/2020